PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1447631
PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1447631
Global Peripheral Intravenous Catheters Market size is expected to record 7.7% CAGR between 2024 and 2032 due to the introduction of supportive devices utilizing catheter systems in the medical sector. The influx of innovations is complementing peripheral intravenous catheters (PIVC) with enhanced functionality and efficacy in various medical procedures. For instance, in October 2023, a medical device, Orchid SRV safety release valve from Linear Health Sciences received expanded FDA indication. This expansion allowed Orchid SRV to be utilized with all IV access methods.
With the development of advanced devices that optimize catheter insertion, securement, and maintenance, healthcare providers are improving patient comfort and safety while ensuring reliable intravenous access. The rising penetration of supportive technologies in the medical sector will also outline the industry expansion.
The overall peripheral intravenous catheters industry is segmented into product, technology, lumen, end-use, and region.
Based on technology, the market share from the conventional PIVC segment will record 7.4% CAGR from 2024 to 2032. These catheters are widely used in healthcare settings for short-term intravenous therapy, emerging pivotal for patient care. With advancements in design and materials, conventional PIVCs offer improved insertion techniques and patient comfort. Their versatility and reliability make them essential for various medical procedures. With healthcare facilities prioritizing patient safety and efficiency, the demand for conventional PIVC segment will continue to rise.
Peripheral intravenous catheters market revenue from the ambulatory surgical centers end-use segment will register 8.6% CAGR from 2024 to 2032. With ambulatory surgical centers (ASCs) increasingly performing outpatient procedures, the need for reliable and efficient intravenous access has become paramount. PIVCs facilitate the safe and convenient delivery of medications and fluids during surgical and diagnostic procedures in these centers. ASCs are also prioritizing cost-effective and minimally invasive solutions, further driving the product demand.
Europe peripheral intravenous catheters industry will record 7.1% CAGR from 2024 to 2032. With a strong focus on advancing medical technology, European hospitals and clinics are seeking reliable and versatile PIVCs to streamline intravenous therapy procedures. With the presence of an aging population and evolving healthcare infrastructure, there is an increasing need for innovative catheter solutions that offer improved patient comfort and reduced risk of complications.